» Articles » PMID: 24586711

Prevention of Neural Tube Defects: a Cross-sectional Study of the Uptake of Folic Acid Supplementation in Nearly Half a Million Women

Overview
Journal PLoS One
Date 2014 Mar 4
PMID 24586711
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Taking folic acid supplements before pregnancy to reduce the risk of a neural tube defect (NTD) is especially important in countries without universal folic acid fortification. The extent of folic acid supplementation among women who had antenatal screening for Down's syndrome and NTDs at the Wolfson Institute of Preventive Medicine, London between 1999 and 2012 was assessed.

Methods And Findings: 466,860 women screened provided details on folic acid supplementation. The proportion of women who took folic acid supplements before pregnancy was determined according to year and characteristics of the women. The proportion of women taking folic acid supplements before pregnancy declined from 35% (95% CI 34%-35%) in 1999-2001 to 31% (30%-31%) in 2011-2012. 6% (5%-6%) of women aged under 20 took folic acid supplements before pregnancy compared with 40% of women aged between 35 and 39. Non-Caucasian women were less likely to take folic acid supplements before pregnancy than Caucasian women; Afro-Caribbean 17% (16%-17%), Oriental 25% (24%-25%) and South Asian 20% (20%-21%) compared with 35% (35%-35%) for Caucasian women. 51% (48%-55%) of women who previously had an NTD pregnancy took folic acid supplements before the current pregnancy.

Conclusions: The policy of folic acid supplementation is failing and has led to health inequalities. This study demonstrates the need to fortify flour and other cereal grain with folic acid in all countries of the world.

Citing Articles

Folic acid supplementation use during the peri-conceptional period among professionals of a hospital in France.

Blanc-Petitjean P, Jezequel M, Manunta A, Olivari-Philiponnet C, Samson E, Bajeux E Prev Med Rep. 2024; 38:102568.

PMID: 38283960 PMC: 10821631. DOI: 10.1016/j.pmedr.2023.102568.


Influence of social, demographic, and clinical factors in live births with spinal dysraphism in Brazil: an ecological study of 21 years.

Oliveira R, Dantas D, Andrade E, Affonso M, de Marin A, Gomes F Childs Nerv Syst. 2023; 39(7):1773-1782.

PMID: 36609513 DOI: 10.1007/s00381-022-05779-y.


A review of current knowledge about the importance of iodine among women of child-bearing age and healthcare professionals.

Kayes L, Mullan K, Woodside J J Nutr Sci. 2022; 11:e56.

PMID: 35836700 PMC: 9274385. DOI: 10.1017/jns.2022.50.


Contribution of base diet, voluntary fortified foods and supplements to micronutrient intakes in the UK.

Bird J, Barron R, Pigat S, Bruins M J Nutr Sci. 2022; 11:e51.

PMID: 35836696 PMC: 9241063. DOI: 10.1017/jns.2022.47.


Folic acid and neural tube defects: Discovery, debate and the need for policy change.

Wald N J Med Screen. 2022; 29(3):138-146.

PMID: 35735352 PMC: 9381685. DOI: 10.1177/09691413221102321.


References
1.
Therapontos C, Erskine L, Gardner E, Figg W, Vargesson N . Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci U S A. 2009; 106(21):8573-8. PMC: 2688998. DOI: 10.1073/pnas.0901505106. View

2.
Huttly W, Wald N, Walters J . Folic acid supplementation before pregnancy remains inadequate. BMJ. 1999; 319(7223):1499. PMC: 1117218. DOI: 10.1136/bmj.319.7223.1499. View

3.
Lopez-Camelo J, Orioli I, Dutra M, Nazer-Herrera J, Rivera N, Ojeda M . Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A. 2005; 135(2):120-5. DOI: 10.1002/ajmg.a.30651. View

4.
Bayston R, Russell A, Wald N, Hoffbrand A . Folic acid fortification and cancer risk. Lancet. 2007; 370(9604):2004. DOI: 10.1016/S0140-6736(07)61861-3. View

5.
Zou G . A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004; 159(7):702-6. DOI: 10.1093/aje/kwh090. View